Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients

Uwe Pichlmeier(Medac (Germany)), Walter Stummer(University of Münster), Gabriele Schackert(University Hospital Carl Gustav Carus), Andrea Bink(University of Zurich)

Neuro-Oncology

July 31, 2008

10.1215/15228517-2008-052

Cited by 327

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

|The Lancet Oncology|2006|3.4k

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

|Neurosurgery|2008|1k

Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients

|Journal of neurosurgery|2000|880

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

|The Lancet|2019|581

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

|Journal of Translational Medicine|2018|540